Literature DB >> 28744407

The use of natural products to target cancer stem cells.

Wesley F Taylor1, Ehsan Jabbarzadeh1,2,3.   

Abstract

The cancer stem cell hypothesis has been used to explain many cancer complications resulting in poor patient outcomes including induced drug resistance, metastases to distant organs, and tumor recurrence. While the validity of the cancer stem cell model continues to be the cause of much scientific debate, a number of putative cancer stem cell markers have been identified making studies concerning the targeting of cancer stem cells possible. In this review, a number of identifying properties of cancer stem cells have been outlined including properties contributing to the drug resistance and metastatic potential commonly observed in supposed cancer stem cells. Due to cancer stem cells' numerous survival mechanisms, the diversity of cancer stem cell markers between cancer types and tissues, and the prevalence of cancer stem cell markers among healthy stem and somatic cells, it is likely that currently utilized treatments will continue to fail to eradicate cancer stem cells. The successful treatment of cancer stem cells will rely upon the development of anti-neoplastic drugs capable of influencing many cellular mechanisms simultaneously in order to prevent the survival of this evasive subpopulation. Natural compounds represent a historically rich source of novel, biologically active compounds which are able to interact with a large number of cellular targets while limiting the painful side-effects commonly associated with cancer treatment. A brief review of select natural products that have been demonstrated to diminish the clinically devastating properties of cancer stem cells or to induce cancer stem cell death is also presented.

Entities:  

Keywords:  Cancer stem cells; alkaloids; cancer recurrence; chemotherapy; drug discovery; drug resistance; flavonoids; metastasis; natural products; polyphenols

Year:  2017        PMID: 28744407      PMCID: PMC5523038     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  104 in total

1.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 2.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

3.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

4.  The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.

Authors:  David Horst; Silvio K Scheel; Sibylle Liebmann; Jens Neumann; Susanne Maatz; Thomas Kirchner; Andreas Jung
Journal:  J Pathol       Date:  2009-12       Impact factor: 7.996

5.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Authors:  Yu-Chih Chen; Yi-Wei Chen; Han-Shui Hsu; Ling-Ming Tseng; Pin-I Huang; Kai-Hsi Lu; Dow-Tien Chen; Lung-Kuo Tai; Ming-Chi Yung; Shih-Ching Chang; Hung-Hai Ku; Shih-Hwa Chiou; Wen-Liang Lo
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

Review 6.  Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.

Authors:  Giuseppe Galati; Peter J O'Brien
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

7.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

8.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

Review 9.  Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

Authors:  Piet Borst
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

10.  How Taxol/paclitaxel kills cancer cells.

Authors:  Beth A Weaver
Journal:  Mol Biol Cell       Date:  2014-09-15       Impact factor: 4.138

View more
  23 in total

1.  Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.

Authors:  Li Wang; Xiangyu Wang; Hanyong Chen; Xueyin Zu; Fayang Ma; Kangdong Liu; Ann M Bode; Zigang Dong; Dong Joon Kim
Journal:  Phytother Res       Date:  2018-12-10       Impact factor: 5.878

Review 2.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

Review 3.  Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Authors:  Anoop K Yadav; Neetin S Desai
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

4.  Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.

Authors:  Ðenana Miodragović; Elden P Swindell; Zohra Sattar Waxali; Abraham Bogachkov; Thomas V O'Halloran
Journal:  Inorganica Chim Acta       Date:  2019-07-24       Impact factor: 3.118

5.  Chemical Constituents of Eupatorium japonicum and Anti-Inflammatory, Cytotoxic, and Apoptotic Activities of Eupatoriopicrin on Cancer Stem Cells.

Authors:  Minh Giang Phan; Thi Thao Do; Thi Nga Nguyen; Thi Viet Huong Do; Ngoc Phuc Dong; Minh Trang Vu
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-18       Impact factor: 2.629

6.  Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1.

Authors:  Thao N D Pham; Sophie Stempel; Mario A Shields; Christina Spaulding; Krishan Kumar; David J Bentrem; Maria Matsangou; Hidayatullah G Munshi
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

7.  Effect of Genistein on Apoptosis and Proliferation of Hepatocellular Carcinoma Hepa1-6 Cell Line.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi; Ali Valiani; Mohamed Amin Ghobadifar
Journal:  Int J Prev Med       Date:  2018-02-08

8.  Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29.

Authors:  Sara Soltanian; Helia Riahirad; Athareh Pabarja; Elham Jafari; Behjat Kalantari Khandani
Journal:  Daru       Date:  2018-09-12       Impact factor: 3.117

Review 9.  Dietary Phytochemicals Targeting Cancer Stem Cells.

Authors:  Alena Liskova; Peter Kubatka; Marek Samec; Pavol Zubor; Milos Mlyncek; Tibor Bielik; Samson Mathews Samuel; Anthony Zulli; Taeg Kyu Kwon; Dietrich Büsselberg
Journal:  Molecules       Date:  2019-03-04       Impact factor: 4.411

Review 10.  Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications.

Authors:  Claudia Peitzsch; Jacqueline Nathansen; Sebastian I Schniewind; Franziska Schwarz; Anna Dubrovska
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.